Bet you didn’t know that they actually named the lack of sexual desire that often accompanies menopause.
I certainly didn’t. But, HSDD, or hypoactive sexual desire disorder, (which is defined in DMV IV as “diminished feelings of sexual interest of desire, absent sexual thoughts/fantasies, or a lack of responsive desire that causes marked distress or interpersonal difficulties, and is not caused by a medical condition or drugs, reportedly affects 1 in 10 women.)
On the other hand, about 70% of women report some decline in sexual desire after menopause. So is HSDD different than the natural decline of sexual “health?” I don’t see researchers making a distinction.
I’ve written about sex numerous times since starting this blog. In fact, I did examine the role of testosterone in sex drive in an earlier post. (You may recall that testosterone, while primarily a male hormone, also plays a role in driving sexual desire in women.)
Researchers are actively studying the safety and effectiveness of a testosterone gel called LibiGel, which when rubbed on the upper arm once a day, evidently raises blood testosterone levels and improves sex drive without causing any serious side effects. What’s more, testosterone gel reportedly does not cause the hair growth and acne often associated with testosterone pills.
I’ve got no argument with the use of testosterone gel; heck, if it’s going to restore sexual desire regardless of declining hormones, I’m all for it. But do we need to call it HSDD, which for all intents and purposes, classify it as problem and not as a natural part of the transition that we call menopause?
I dunno; it feels a bit clinical to me. What do you think?
No Comments
Trackbacks/Pingbacks